Chenghai Li Selected Research

Chenghai Li Research Topics

7	Neoplasms (Cancer) 01/2021 - 12/2009
3	Inflammation (Inflammations) 01/2021 - 01/2020
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2024 - 02/2018
2	Tuberculosis (Tuberculoses) 01/2024 - 08/2020
2	COVID-19 01/2021 - 01/2020
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 03/2024
1	Leiomyoma (Uterine Fibroids) 01/2022
1	Hyperthermia 01/2021
1	Carcinogenesis 01/2021
1	Acute-Phase Reaction 01/2021
1	Communicable Diseases (Infectious Diseases) 01/2020
1	Infections 01/2019
1	Lung Neoplasms (Lung Cancer) 02/2018
1	Bone Fractures (Bone Fracture) 01/2018
1	Soft Tissue Injuries (Soft Tissue Injury) 01/2018
1	Osteoporosis 01/2016
1	Hypersensitivity (Allergy) 11/2015
1	Disease Progression 09/2012
1	Polycystic Kidney Diseases (Polycystic Kidney Disease) 09/2012
1	Cysts 09/2012
1	Renal Cell Carcinoma (Grawitz Tumor) 11/2011
1	Necrosis 11/2011
1	Colonic Neoplasms (Colon Cancer) 10/2010
1	Pancreatic Neoplasms (Pancreatic Cancer) 04/2010
1	Breast Neoplasms (Breast Cancer) 12/2009

3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 04/2010
2	VaccinesIBA 01/2021 - 01/2020
2	Metalloproteases (Metalloproteinases)IBA 09/2012 - 12/2009
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2011 - 04/2010
2	NF-kappa B (NF-kB)IBA 10/2010 - 04/2010
1	Insulin (Novolin)FDA Link 03/2024
1	dapagliflozinIBA 03/2024
1	Biomarkers (Surrogate Marker)IBA 01/2024
1	Nucleic AcidsIBA 01/2024
1	CytokinesIBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	AntibodiesIBA 01/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2020
1	Antiviral Agents (Antivirals)IBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	Tyrosine Kinase InhibitorsIBA 02/2018
1	ErbB Receptors (EGF Receptor)IBA 02/2018
1	RANK LigandIBA 01/2016
1	Interleukin-2 (IL2)IBA 11/2015
1	Collagen Type I (Type I Collagen)IBA 09/2012
1	Doxycycline (Periostat)FDA LinkGeneric 09/2012
1	Matrix Metalloproteinases (MMPs)IBA 09/2012
1	CollagenIBA 09/2012
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 09/2012
1	Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA 11/2011
1	dauricineIBA 10/2010
1	maslinic acidIBA 04/2010
1	SurvivinIBA 04/2010
1	Cyclin D1IBA 04/2010
1	CaspasesIBA 04/2010
1	Inhibitor of Differentiation Protein 1IBA 12/2009

7	Therapeutics 03/2024 - 01/2018
2	Immunomodulation 01/2021 - 01/2020
1	High-Intensity Focused Ultrasound Ablation 01/2022
1	Punctures 08/2020
1	Radiotherapy 02/2018